Description
Kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults. The recommended target dose is 20 mg finerenone once daily. The maximum recommended dose is 20 mg finerenone once daily.
Reviews
There are no reviews yet.